Fear of COVID-19 and workplace phobia among Pakistani doctors: A survey study.


Journal

BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562

Informations de publication

Date de publication:
30 04 2021
Historique:
received: 16 12 2020
accepted: 16 04 2021
entrez: 1 5 2021
pubmed: 2 5 2021
medline: 15 5 2021
Statut: epublish

Résumé

The novel coronavirus disease-2019 (COVID-19) has seriously affected the lives of millions of people across the world. It has also heavily burdened healthcare professionals and the virus poses serious risks for their personal and professional lives. Therefore, the present study examined the associations between fear of COVID-19 and workplace phobia among doctors in Pakistan during the COVID-19 pandemic. An online survey was conducted among 421 doctors in Pakistan between April 10 and May 25, 2020. The Workplace Phobia Scale (WPS) and the Fear of COVID-19 Scale (FCV-19S) were the main psychometric instruments used in this study. There was a significant positive relationship between fear of COVID-19 and workplace panic anxiety and workplace avoidance behavior. Significantly higher fear of COVID-19 was found among (i) females compared to males, (ii) doctors with 5 years or less of work experience compared to those with more than 5 years, and (iii) postgraduate trainees compared with other ranks. Two groups (doctors who were above 30 years old and postgraduate trainees) were found to have higher levels of workplace phobia compared to their counterparts. Doctors with severe levels of fear of COVID-19 had significantly higher levels of workplace panic anxiety and workplace avoidance behavior. Fear of COVID-19 was significantly associated with workplace phobia which may negatively affect doctors' performance. Therefore, important steps are needed to protect doctors' health by providing sufficient resources to allay their fears and anxieties which consequently help them in carrying out their frontline duties in response to the COVID-19 pandemic.

Sections du résumé

BACKGROUND
The novel coronavirus disease-2019 (COVID-19) has seriously affected the lives of millions of people across the world. It has also heavily burdened healthcare professionals and the virus poses serious risks for their personal and professional lives. Therefore, the present study examined the associations between fear of COVID-19 and workplace phobia among doctors in Pakistan during the COVID-19 pandemic.
METHODS
An online survey was conducted among 421 doctors in Pakistan between April 10 and May 25, 2020. The Workplace Phobia Scale (WPS) and the Fear of COVID-19 Scale (FCV-19S) were the main psychometric instruments used in this study.
RESULTS
There was a significant positive relationship between fear of COVID-19 and workplace panic anxiety and workplace avoidance behavior. Significantly higher fear of COVID-19 was found among (i) females compared to males, (ii) doctors with 5 years or less of work experience compared to those with more than 5 years, and (iii) postgraduate trainees compared with other ranks. Two groups (doctors who were above 30 years old and postgraduate trainees) were found to have higher levels of workplace phobia compared to their counterparts. Doctors with severe levels of fear of COVID-19 had significantly higher levels of workplace panic anxiety and workplace avoidance behavior.
CONCLUSIONS
Fear of COVID-19 was significantly associated with workplace phobia which may negatively affect doctors' performance. Therefore, important steps are needed to protect doctors' health by providing sufficient resources to allay their fears and anxieties which consequently help them in carrying out their frontline duties in response to the COVID-19 pandemic.

Identifiants

pubmed: 33931040
doi: 10.1186/s12889-021-10873-y
pii: 10.1186/s12889-021-10873-y
pmc: PMC8086971
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

833

Références

Asian J Psychiatr. 2020 Jun;51:102119
pubmed: 32339895
Brain Behav Immun. 2020 Aug;88:901-907
pubmed: 32437915
BMJ. 2020 Feb 18;368:m641
pubmed: 32071063
Emerg Infect Dis. 2005 Mar;11(3):404-10
pubmed: 15757555
F1000Res. 2020 Nov 6;9:1304
pubmed: 33447383
N Engl J Med. 2020 Apr 30;382(18):1681-1683
pubmed: 32163699
Cureus. 2020 Aug 14;12(8):e9741
pubmed: 32944456
Int J Ment Health Addict. 2020 Jul 12;:1-11
pubmed: 32837443
Psychol Bull. 1992 Jul;112(1):155-9
pubmed: 19565683
Postgrad Med J. 2020 Aug 25;:
pubmed: 32843485
J Infect Public Health. 2020 Jun;13(6):877-882
pubmed: 32505461
Med Care. 2005 Jul;43(7):676-82
pubmed: 15970782
Policy Sci. 2020 Apr 18;:1-17
pubmed: 32313308
J Nurs Manag. 2021 Apr;29(3):395-403
pubmed: 32985046
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
Pak J Med Sci. 2020 May;36(COVID19-S4):S37-S42
pubmed: 32582312
Lancet Glob Health. 2020 Jun;8(6):e790-e798
pubmed: 32573443
Lancet Infect Dis. 2020 Jul;20(7):773
pubmed: 32171390
Int J Environ Res Public Health. 2020 Oct 27;17(21):
pubmed: 33120930
J Glob Health. 2020 Jun;10(1):010357
pubmed: 32509288
Epilepsy Behav. 2020 Nov;112:107371
pubmed: 32861897
Int J Ment Health Addict. 2020 Mar 27;:1-9
pubmed: 32226353
Occup Med (Lond). 2020 Jul 17;70(5):317-319
pubmed: 32239155
Postgrad Med J. 2007 May;83(979):317-9
pubmed: 17488860
Nature. 2020 Aug;584(7820):262-267
pubmed: 32512578
Psychol Health Med. 2009 Oct;14(5):591-605
pubmed: 19844838
Int J Clin Pract. 2021 Apr;75(4):e13889
pubmed: 33280187
Gerontol Geriatr Med. 2020 Oct 26;6:2333721420966081
pubmed: 33195740
Med Educ. 2011 May;45(5):488-96
pubmed: 21486324
Psychother Psychosom. 2020;89(4):242-250
pubmed: 32272480
Lancet Infect Dis. 2018 Nov;18(11):1162-1163
pubmed: 30243585
Genome Biol. 2020 May 11;21(1):113
pubmed: 32393316
Int J Health Plann Manage. 2020 Sep;35(5):1041-1054
pubmed: 32700410
J Am Board Fam Med. 2014 Jul-Aug;27(4):486-94
pubmed: 25002003
Pak J Med Sci. 2020 May;36(COVID19-S4):S99-S103
pubmed: 32582323
Int Braz J Urol. 2020 Jul;46(suppl.1):195-200
pubmed: 32618464
Pak J Med Sci. 2016 Mar-Apr;32(2):294-8
pubmed: 27182226
BMJ. 2020 Jan 28;368:m313
pubmed: 31992552
Ann Intern Med. 2020 Jul 21;173(2):120-136
pubmed: 32369541

Auteurs

Sadia Malik (S)

Department of Psychology, University of Sargodha, Sargodha, Pakistan.

Irfan Ullah (I)

Kabir Medical College, Gandhara University, Peshawar, 25000, Pakistan.

Muhammad Irfan (M)

Internal Medicine, Hayatabad Medical Complex, Peshawar, Pakistan.

Daniel Kwasi Ahorsu (DK)

Department of Rehabilitation Sciences, Faculty of Health & Social Sciences, The Hong Kong Polytechnic University, Hung Hom, RM QT 512, Hong Kong, China. daniel.ahorsu@connect.polyu.hk.

Chung-Ying Lin (CY)

Institute of Allied Health Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan.

Amir H Pakpour (AH)

Social Determinants of Health Research Center, Research Institute for Prevention of Non-Communicable Diseases, Qazvin University of Medical Sciences, ShahidBahounar BLV, Qazvin, 3419759811, Iran. Pakpour_Amir@yahoo.com.
Department of Nursing, School of Health and Welfare, Jönköping University, Jönköping, Sweden. Pakpour_Amir@yahoo.com.

Mark D Griffiths (MD)

International Gaming Research Unit, Psychology Department, Nottingham Trent University, 50 Shakespeare Street, Nottingham, NG1 4FQ, UK.

Ibad Ur Rehman (IU)

Shifa College of Medicine, Shifa Tameer-e-Millat University, Islamabad, Pakistan.

Rafia Minhas (R)

Avicenna Medical and Dental College, Lahore, Pakistan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH